Broadcast Date: 
  • Time: 

There is intense interest in research applications of organoids—mini-organs grown in a dish that are made up of different cell types that self-organize into tissue assemblies. By accurately mimicking human tissue biology, organoids hold great promise to revolutionize scientific discovery and healthcare with multimodal potential for new drug development, precision medicine, and regenerative medicine. Human organoids can be derived from either human pluripotent stem cells (hPSCs) or primary biopsy or autopsy tissues. However, there are significant challenges in quality control and reproducibility.

In this webinar, two experts in 3D cell culture and organoid biology will share their expertise on this exciting field. Dr. Elizabeth Abraham (Corning Life Sciences) will discuss the latest developments in 3D cell culture, including key applications, new tools and technologies, and bridging the pre-clinical gap. The main presentation will be given by Dr. Lauretta Lacko (Weill Cornell Medicine), who will discuss the myriad medical applications of organoids. She will draw on her insights running the Human Therapeutic Organoid Core (HTOC) facility, providing quality organoids to the scientific community, in particular the value of sourcing high-quality reagents and optimizing protocols.

A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelists.

Elizabeth Abraham, PhD
Elizabeth Abraham, PhD
Market Manager,
3D Cell Culture
Corning Life Sciences
Lauretta Lacko
Lauretta A. Lacko, PhD
Assistant Professor of Cell Biology Research
Weill Cornell Medicine

corning logo